Literature DB >> 9022432

Severe persistent visual field constriction associated with vigabatrin.

T Eke1, J F Talbot, M C Lawden.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9022432      PMCID： PMC2125673          DOI： 10.1136/bmj.314.7075.180

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  104 in total

1.  Visual field defect associated with vigabatrin. Many more patients may be affected than were found in study.

Authors:  I F Comaish; C Gorman; N R Galloway
Journal:  BMJ       Date:  2000-05-20

2.  Guideline for prescribing vigabatrin in children has been revised. Vigabatrin Paediatric Advisory Group.

Authors: 
Journal:  BMJ       Date:  2000-05-20

3.  Visual field defect associated with vigabatrin: observational cohort study.

Authors:  L V Wilton; M D Stephens; R D Mann
Journal:  BMJ       Date:  1999-10-30

4.  Long term changes in the visual fields of patients with temporal lobe epilepsy using vigabatrin.

Authors:  P Hardus; W M Verduin; G Postma; J S Stilma; T T Berendschot; C W van Veelen
Journal:  Br J Ophthalmol       Date:  2000-07       Impact factor: 4.638

5.  The management of epilepsy.

Authors:  D Smith; D Chadwick
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-06       Impact factor: 10.154

6.  Vigabatrin and retinal changes.

Authors:  Hanne Jensen; Ole Sjö; Peter Uldall; Lennart Gram
Journal:  Doc Ophthalmol       Date:  2002-03       Impact factor: 2.379

7.  GABA(C) receptors modulate the rod-driven ERG b-wave of the skate retina.

Authors:  Richard L Chappell; Etha Schuette; Robert Anton; Harris Ripps
Journal:  Doc Ophthalmol       Date:  2002-09       Impact factor: 2.379

8.  Contrast and glare sensitivity in epilepsy patients treated with vigabatrin or carbamazepine monotherapy compared with healthy volunteers.

Authors:  I Nousiainen; R Kälviäinen; M Mäntyjärvi
Journal:  Br J Ophthalmol       Date:  2000-06       Impact factor: 4.638

9.  Vigabatrin add-on therapy for drug-resistant focal epilepsy.

Authors:  Rebecca Bresnahan; Myrsini Gianatsi; Melissa J Maguire; Catrin Tudur Smith; Anthony G Marson
Journal:  Cochrane Database Syst Rev       Date:  2020-07-30

10.  CPP-115, a vigabatrin analogue, decreases spasms in the multiple-hit rat model of infantile spasms.

Authors:  Stephen W Briggs; Wenzhu Mowrey; Charles B Hall; Aristea S Galanopoulou
Journal:  Epilepsia       Date:  2013-10-28       Impact factor: 5.864
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.